Who we are
Initiative
Falsified (fake) medicines have become a scourge threatening Public Health on a worldwide scale. In order to confront the danger of falsified drugs intruding in the legal distribution chain of pharmaceuticals, stakeholders of the pharmaceutical sector have joint forces, for the development and implementation of a trustworthy verification system which will enable health professionals to check the authenticity of medication before these are dispensed to the patients. The implementation of such a system is necessary, in order for Member States to comply with the legal requirements of the EU for falsified medicine.
Who we are
The Cyprus Medicines Verification Organization (CyMVO) was established in February 2017 as a non-profit legal entity with Main Members the Cyprus Association of Pharmaceutical Research and Development Companies (KEFEA) and the Pancyprian Association of Generic Medicines Manufacturers (PASYPAGEF). Affiliate Members are, the Cyprus Pharmaceutical Association (CPA), the Pharmaceutical Services of the Ministry of Health, the Association of Cyprus Pharmaceutical Companies (SFEK), the parallel importer Krinera Ltd and the pharmaceutical wholesalers MEFAL, KEDIFAP and Blue Pharmacies. Director of the CyMVO is Mr. Arthur Isseyegh.
The basic mandate of KOEF is to create and effectively implement the Cyprus Drug Verification System (CyMVS), to support all the entities that have the obligation to implement it and to continuously monitor its operation, so as to bring about the desired results. The statutes for the establishment of the KOEF include, among others, actions such as, the organizing of lectures, workshops, seminars, conferences, for training the stakeholders and raising public awareness.
Quality Statement
CyMVO acknowledges its responsibility for safety of medicines within Cyprus. Therefore, the CyMVO will ensure the implementation of a national medicines verification system that complies with the Falsified Medicines Directive and the Delegated Regulation. The CyMVO strives to a continuously available and easy-to-use system by improving its quality management processes
Quality objectives
Quality objectives are established to implement the quality policy and to continuously improve the quality management system and the quality performance. The following section describes the quality objectives, based on the Quality Policy that was defined. The quality objectives take the goal(s) stated in the Quality Policy and turn these into statements for improvement against which plans can be made.
- A fully operational CyMVS system will be up and running before the 1st of February 2019.
- 100% of the national pharmacies and wholesalers on-boarded before the 1st of February 2019.
- Quality System (QMS) will be 100% created, setup and operational before the 1st of February 2019.
- CyMVO personnel are trained in accordance to QMS procedures and policies. The records for all the training programs and the assessments are kept in the personal file of each employee.
- GDPR legislation requirements are defined and implemented across all organization operations.
Members








Συντμήσεις
ΚΕΦΕΑ: Κυπριακή Ένωση Φαρμακευτικών Εταιρειών Έρευνας και Ανάπτυξης
ΠΑEΦ: Παγκύπρια ‘Ενωση Φαρμακοβιομηχανιών Λτδ
ΣΦΕΚ: Σύνδεσμος Φαρμακευτικών Εταιρειών Κύπρου
ΚΡΙΝΕΡΑ: Παράλληλος Εισαγωγέας
ΠΦΣ: Παγκύπριος Φαρμακευτικός Σύλλογος
ΜΕΦΑΛ: Φαρμακευτική Αποθήκη με βάση τη Λάρνακα
ΚΕΔΙΦΑΠ: Φαρμακευτική Αποθήκη με βάση την Πάφο
BLUE PHARMACIES: Φαρμακευτική Αποθήκη με βάση τη Λεμεσό
External partners
The Chanteclair House,2, Sophoulis Street, 9th floor, 1096 Nicosia, Cyprus
Tel.: (+357) 22 676060 | Fax : (+357) 22 676061 | info@ldlaw.com.cy
The Chanteclair House, 2, Sophoulis Street, 8th floor, 1096 Nicosia, Cyprus
Tel.: (+357) 22 456111 | Fax: (+357) 22 666276 | np@nexia.com.cy